Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

A.A. van de Loosdrecht, R. Ireland, W. Kern, M.G. la Porta, C. Alhan, J.S. Balleisen, P. Bettelheim, D.T. Bowen, K. Burbury, L. Eidenschink, M. Cazzola, S.S.C. Chu, M. Cullen, J.A. Cutler, A.M. Drager, J. Feuillard, P. Fenaux, P. Font, U. Germing, D. HaaseE. Hellstrom-Lindberg, U. Johansson, S. Kordasti, M.R. Loken, L. Malcovati, J.G. te Marvelde, S. Matarraz, T. Milne, B. Moshaver, G.J. Mufti, V. Nikolova, K. Ogata, U. Oelschlaegel, A. Orfao, G.J. Ossenkoppele, A. Porwit, U. Platzbecker, F. Preijers, K. Psarra, S.J. Richards, D. Subira, J.F. Seymour, V. Tindell, T. Vallespi, P. Valent, V.H.J. van der Velden, D.A. Wells, T.M. de Witte, F. Zettl, M.C. Bene, T.M. Westers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)472-475
JournalLeukemia and Lymphoma
Volume54
Issue number3
DOIs
Publication statusPublished - 2013

Cite this